⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NUVB News
Nuvation Bio Inc.
Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers
prnewswire.com
NUVB
Nuvation Bio Announces IBTROZI® (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026
prnewswire.com
NUVB
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
globenewswire.com
NUVB
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nuvation Bio Inc. (NUVB) And Encourages Shareholders to Reach Out
accessnewswire.com
NUVB
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nuvation Bio Inc. (NUVB) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
NUVB
Nuvation Bio Inc. (NUVB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
NUVB
Bronstein, Gewirtz & Grossman, LLC Encourages Nuvation Bio Inc. (NUVB) Shareholders to Inquire about Securities Investigation
accessnewswire.com
NUVB
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
prnewswire.com
NUVB
Nuvation Bio Inc. (NUVB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
NUVB
Bronstein, Gewirtz & Grossman, LLC Is Investigating Nuvation Bio Inc. (NUVB) And Encourages Investors to Connect
accessnewswire.com
NUVB